Short Report

You have full text access to this OnlineOpen article

Sheep stromal-epithelial cell interactions and ovarian tumor progression

  1. Feng Wang-Johanning1,†,*,
  2. Miao Huang1,
  3. Jinsong Liu2,
  4. Kiera Rycaj1,
  5. Joshua B. Plummer1,
  6. Kirstin F. Barnhart1,
  7. William C. Satterfield1,
  8. Gary L. Johanning1

Article first published online: 26 JUL 2007

DOI: 10.1002/ijc.22960

Issue

International Journal of Cancer

International Journal of Cancer

Volume 121, Issue 10, pages 2346–2354, 15 November 2007

Additional Information

How to Cite

Wang-Johanning, F., Huang, M., Liu, J., Rycaj, K., Plummer, J. B., Barnhart, K. F., Satterfield, W. C. and Johanning, G. L. (2007), Sheep stromal-epithelial cell interactions and ovarian tumor progression. Int. J. Cancer, 121: 2346–2354. doi: 10.1002/ijc.22960

Author Information

  1. 1

    Department of Veterinary Sciences, Michale E. Keeling Center for Comparative Medicine and Research, The University of Texas M.D. Anderson Cancer Center, Bastrop, TX

  2. 2

    Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

  1. †

    Fax: +512-332-5218.

*Departments of Veterinary Sciences and Immunology, The University of Texas M.D. Anderson Cancer Center, 650 Cool Water Drive, Houston, TX 78602, USA

Publication History

  1. Issue published online: 25 SEP 2007
  2. Article first published online: 26 JUL 2007
  3. Manuscript Accepted: 21 MAY 2007
  4. Manuscript Received: 22 NOV 2006

Funded by

  • Susan G. Komen Breast Cancer Foundation. Grant Number: BCTR0402892
  • M.D. Anderson Cancer Center

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (1806K)

References

  • 1
    Bhoola S, Hoskins WJ. Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol 2006; 107: 1399–410.
  • 2
    Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002; 94: 2766–92.
    Direct Link:
  • 3
    Holschneider CH, Berek JS. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 2000; 19: 3–10.
    Direct Link:
  • 4
    Jiang F, Saunders BO, Haller E, Livingston S, Nicosia SV, Bai W. Conditionally immortal ovarian cell lines for investigating the influence of ovarian stroma on the estrogen sensitivity and tumorigenicity of ovarian surface epithelial cells. In Vitro Cell Dev Biol Anim 2003; 39: 304–12.
  • 5
    Liotta LA, Kohn EC, Petricoin EF. Clinical proteomics: personalized molecular medicine. JAMA 2001; 286: 2211–14.
  • 6
    Kleiman A, Senyuta N, Tryakin A, Sauter M, Karseladze A, Tjulandin S, Gurtsevitch V, Mueller-Lantzsch N. HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors. Int J Cancer 2004; 110: 459–61.
    Direct Link:
  • 7
    Vanderhyden BC, Shaw TJ, Ethier JF. Animal models of ovarian cancer. Reprod Biol Endocrinol 2003; 1: 67.
  • 8
    Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, Hamilton TC. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 2003; 63: 1389–97.
  • 9
    Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, Weinberg RA. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002; 22: 2111–23.
  • 10
    Ludlow JW. Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J 1993; 7: 866–71.
  • 11
    Moran E. Interaction of adenoviral proteins with pRB and p53. FASEB J 1993; 7: 880–5.
  • 12
    Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89: 213–28.
  • 13
    Akagi T, Sasai K, Hanafusa H. Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc Natl Acad Sci USA 2003; 100: 13567–72.
  • 14
    Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA 1998; 95: 14723–8.
  • 15
    Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 2001; 15: 50–65.
  • 16
    Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin AS,Jr. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 1997; 278: 1812–15.
  • 17
    Yarde WL, Arnold PM, Kepes JJ, O'Boynick PL, Wilkinson SB, Batnitzky S. Synovial cysts of the lumbar spine: diagnosis, surgical management, and pathogenesis. Report of eight cases. Surg Neurol 1995; 43: 459–64; discussion 65.
  • 18
    Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer 2005; 5: 867–75.
  • 19
    Condon MS. The role of the stromal microenvironment in prostate cancer. Semin Cancer Biol 2005; 15: 132–7.
  • 20
    Liotta LA, Kohn EC. Stromal therapy: the next step in ovarian cancer treatment. J Natl Cancer Inst 2002; 94: 1113–14.
  • 21
    Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME, Nicosia SV. Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev Biol Anim 2000; 36: 657–66.
  • 22
    Parrott JA, Nilsson E, Mosher R, Magrane G, Albertson D, Pinkel D, Gray JW, Skinner MK. Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells. Mol Cell Endocrinol 2001; 175: 29–39.
  • 23
    Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, Rosen DG, Chen DT, Lu DW, Barnhart KF, Johanning GL. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer 2007; 120: 81–90.
    Direct Link:
  • 24
    Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast RC,Jr, Zhou C, Liu J. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Carcinogenesis 2007; 28: 174–82.
  • 25
    Galli UM, Sauter M, Lecher B, Maurer S, Herbst H, Roemer K, Mueller-Lantzsch N. Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene 2005; 24: 3223–8.
  • 26
    Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A, Marquez RT, Auersperg N, Yu Y, Hahn WC, Mills GB, Bast RC,Jr. A genetically defined model for human ovarian cancer. Cancer Res 2004; 64: 1655–63.
  • 27
    Nitta M, Katabuchi H, Ohtake H, Tashiro H, Yamaizumi M, Okamura H. Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen. Gynecol Oncol 2001; 81: 10–17.
  • 28
    Egeblad M, Littlepage LE, Werb Z. The fibroblastic coconspirator in cancer progression. Cold Spring Harbor Symp Quant Biol 2005; 70: 383–8.
  • 29
    Yang G, Rosen DG, Zhang Z, Bast RC,Jr, Mills GB, Colacino JA, Mercado-Uribe I, Liu J. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci USA 2006; 103: 16472–7.
View Full Article (HTML) Get PDF (1806K)